Hjem › Blærecancer › Colorado › Denver
Blærecancer kliniske forsøg i Denver, CO
11 studier for Blærecancer søger deltagere på steder i og omkring Denver (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
RekruttererFase 1
- Sarah Cannon Research Institute at HealthOne, Denver
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
- AdventHealth Porter, Denver
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
RekruttererFase 2
- UCHealth - Cherry Creek, Denver
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
RekruttererFase 1/2
- Rocky Mountain Cancer Centers, LLP, Denver
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
RekruttererFase 3
- AdventHealth Medical Group - Porter, Denver
The Vanguard Study: Testing a New Way to Screen for Cancer
RekruttererFrivillige med god helbredstilstand velkomne
- Kaiser Permanente-Franklin, Denver
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
RekruttererFase 2
- AdventHealth Medical Group Urology of Denver, Denver
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
RekruttererFase 3
- UCHealth - Cherry Creek, Denver
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
RekruttererFase 2/3
- Rocky Mountain Cancer Centers, LLP, Denver
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
RekruttererFase 1/2
- Sarah Cannon Research Institute at HealthONE, Denver
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservationsstudie
- Massive Bio SYNERGY-AI site, Denver
Blærecancer forsøg i andre byer
- New York City, NY35 studier
- Nashville, TN31 studier
- Houston, TX31 studier
- Dallas, TX27 studier
- Boston, MA26 studier
- Washington, DC26 studier
- Los Angeles, CA24 studier
- Baltimore, MD24 studier
- St. Louis, MO22 studier
- Philadelphia, PA21 studier
- Seattle, WA21 studier
- Edison, NJ21 studier
Andre studier i Denver
- Metastatisk cancer29 studier
- Brystkræft28 studier
- Multipelt myelom27 studier
- Ikke-småcellet lungecancer27 studier
- Colorektal kræft23 studier
- Prostatakræft19 studier
- Melanom19 studier
- Kræft (alle typer)18 studier
- Ægstockræft16 studier
- Lungecancer16 studier
- Livmoderslimhindekræft15 studier
- Non-Hodgkin lymfom14 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.